BioSpace News Archive

Biotech Beach

MassRoots Preparing Launch of CBD Product-Focused Review and E-Commerce Platform

Aims to be a leading information portal for millions of consumers interested in CBD products; exploring E-Commerce for hemp-derived CBD products following passage of the Farm Bill

December 20, 2018
·
3 min read
Job Trends

The Growth of Non-Industrial Robotics Is Driving a Diversification of New Robotics Applications, According to Tractica

More than 100 Discrete Use Cases Are Fueling Market Growth in Enterprise, Consumer, Government, and Military Robots

December 20, 2018
·
2 min read
Business

Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies

-- Agenus Webcast and Conference Call Scheduled for Today at 8:30a.m.ET --

December 20, 2018
·
6 min read
Mylan to Present at the 37th Annual J.P. Morgan Healthcare Conference

Mylan N.V. today announced that CEO Heather Bresch will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, Jan. 8, 2019, at 11 a.m. PT / 2 p.m. ET.

December 20, 2018
·
1 min read
Business

Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters

Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million

December 20, 2018
·
13 min read
Business

Intrexon and Merck KGaA, Darmstadt, Germany, Announce Agreement Realizing Precigen’s Vision for Full Developmental Autonomy of its CAR-T Program

Merck KGaA, Darmstadt, Germany, to assign its Chimeric Antigen Receptor T-cell (CAR-T) rights to Intrexon

December 20, 2018
·
6 min read
Deals

Dicerna to Join NASDAQ Biotechnology Index

Dicerna Pharmaceuticals, Inc. today announced that the Company will be added to the NASDAQ Biotechnology Index (Nasdaq:NBI) as part of the annual re-ranking, which will become effective prior to market open on Monday, December 24, 2018.

December 20, 2018
·
2 min read
Drug Development

Kalytera Provides Update on Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD

No Patients Have Developed Grades 3-4 Acute GVHD While Receiving CBD Treatment

December 20, 2018
·
10 min read
Business

Gilead Sciences and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies

-- Agenus Conference Call Scheduled for Today at 8:30 a.m. ET --

December 20, 2018
·
6 min read
Policy

Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon

Agreement enables Merck KGaA, Darmstadt, Germany, to maintain an investment in the rapidly advancing oncology field of CAR-T, while focusing its R&D efforts

December 20, 2018
·
4 min read